Dr. Emma Guttman-Yassky
Claim this profileIcahn School of Medicine at Mount Sinai
Affiliated Hospitals
Icahn School Of Medicine At Mount Sinai
Icahn Sch Of Med At Mt. Sinai
Clinical Trials Emma Guttman-Yassky is currently running
Dupilumab
for Alopecia Areata
This trial tests a new treatment for children and adolescents with significant hair loss due to Alopecia Areata. The treatment likely helps the immune system stop attacking hair follicles, allowing hair to regrow. Oral tofacitinib has shown promising results in treating alopecia areata in children.
Recruiting
0 awards
Phase 2
7 criteria
Dupilumab
for Alopecia Areata
This is a prospective, randomized, double blind, placebo-controlled clinical trial. The study will take place at 4 sites. This trial will enroll a total of 68 patients with moderate to severe AA (affecting more than 50% of the scalp) at the time of screening with a targeted 54 subjects completers through Week 48. AA subjects must have evidence of hair regrowth within the last 7 years of their last episode of hair loss; and have screening IgE ≥ 200 and/or have personal and/or familial history of atopy. Subjects will be randomized (2:1) to either receive weekly dupilumab or placebo for 48 weeks, with all subjects completing participation through Week 48 receiving an additional 48 weeks of dupilumab (through Week 96).
Recruiting
0 awards
Phase 2
7 criteria
More about Emma Guttman-Yassky
Clinical Trial Related
2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Emma Guttman-Yassky has experience with
- Dupilumab
- Placebo
- Ritlecitinib
- Lebrikizumab
- GSK1070806
Breakdown of trials Emma Guttman-Yassky has run
Alopecia Areata
Atopic Dermatitis
Medical Device Dermatitis
Skin Conditions
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Emma Guttman-Yassky specialize in?
Emma Guttman-Yassky focuses on Alopecia Areata and Atopic Dermatitis. In particular, much of their work with Alopecia Areata has involved treating patients, or patients who are undergoing treatment.
Is Emma Guttman-Yassky currently recruiting for clinical trials?
Yes, Emma Guttman-Yassky is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Emma Guttman-Yassky has studied deeply?
Yes, Emma Guttman-Yassky has studied treatments such as Dupilumab, Placebo, Ritlecitinib.
What is the best way to schedule an appointment with Emma Guttman-Yassky?
Apply for one of the trials that Emma Guttman-Yassky is conducting.
What is the office address of Emma Guttman-Yassky?
The office of Emma Guttman-Yassky is located at: Icahn School of Medicine at Mount Sinai, New York, New York 10029 United States. This is the address for their practice at the Icahn School of Medicine at Mount Sinai.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.